GDI2 and neoplasm: As for the clinicopathological correlation for HCC patients, it was found that the expression of GDI2 was increased as the disease progressed, especially for the HCC patients in late T stage, advanced pathologic stage, poor histologic grade, and with bad tumor status (*P < 0.05) (Figure 4).